nevirapine has been researched along with Addiction, Opioid in 5 studies
Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Buprenorphine CL/F was 76% higher in HIV+ patients (n = 17) than HIV- patients (n = 37)." | 1.72 | Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability. ( Bart, G; Brundage, RC; Giang, LM; Jaber, M; Korthuis, PT, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bart, G | 3 |
| Jaber, M | 3 |
| Giang, LM | 3 |
| Brundage, RC | 3 |
| Korthuis, PT | 3 |
| Altice, FL | 1 |
| Friedland, GH | 1 |
| Cooney, EL | 1 |
| Otero, MJ | 1 |
| Fuertes, A | 1 |
| Sánchez, R | 1 |
| Luna, G | 1 |
| Baño Rodrigo, MD | 1 |
| Agujetas Rodríguez, M | 1 |
| López García, ML | 1 |
| Guillén Llera, JL | 1 |
| Eap, CB | 1 |
5 other studies available for nevirapine and Addiction, Opioid
| Article | Year |
|---|---|
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Findings from a pilot study of buprenorphine population pharmacokinetics: A potential effect of HIV on buprenorphine bioavailability.
Topics: Biological Availability; Buprenorphine; HIV Infections; Humans; Nevirapine; Opioid-Related Disorders | 2022 |
Nevirapine induced opiate withdrawal among injection drug users with HIV infection receiving methadone.
Topics: Adult; Anti-HIV Agents; Drug Interactions; Female; HIV Infections; Humans; Male; Methadone; Middle A | 1999 |
Nevirapine-induced withdrawal symptoms in HIV patients on methadone maintenance programme: an alert.
Topics: Adult; Anti-HIV Agents; Drug Interactions; HIV Infections; Humans; Methadone; Narcotics; Nevirapine; | 1999 |
[Nevirapine induces abstinence symptoms in patients on a methadone maintenance program with HIV infection].
Topics: Adult; Analysis of Variance; Anti-HIV Agents; Chronic Disease; Drug Interactions; Drug Therapy, Comb | 2000 |
Comment: opiate withdrawal symptoms induced by antiretroviral drugs.
Topics: Alkynes; Analgesics, Opioid; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Humans; Methadone; Nevira | 2000 |